CEO/Co-founder
Matrubials
Matrubials develops novel antibacterial therapeutics derived from mammalian milk to address non-selective action and emerging antimicrobial resistance. The company utilizes an AI-enabled platform to identify and validate bioactive antimicrobial peptides for diverse therapeutic indications. Initial focus is on developing topical therapeutics for Bacterial Vaginosis to reduce associated clinical complications.
- Biotechnology
Updated yesterday
Funding
Raised to date
$130KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Matrubials develops novel antibacterial therapeutics derived from mammalian milk to address non-selective action and emerging antimicrobial resistance. The company utilizes an AI-enabled platform to identify and validate bioactive antimicrobial peptides for diverse therapeutic indications. Initial focus is on developing topical therapeutics for Bacterial Vaginosis to reduce associated clinical complications.